Abbott Rapid Diagnostics Informatics, Inc., a subsidiary of Abbott Laboratories, received a firm fixed-price purchase order from the Defense Health Agency valued at $145,627.50 for i-STAT module license fees, including Nova module licensing, interface, connection, and implementation services. The contract, awarded September 30, 2023, will support Defense Health Agency operations through September 29, 2028, with performance taking place in Japan. This award carries no small business set-aside designation and reflects Abbott's established role as a critical technology partner for federal healthcare agencies specializing in point-of-care medical device integration and data management solutions.
The i-STAT analyzer system represents Abbott's widely deployed diagnostic platform for federal healthcare facilities, enabling seamless data exchange between medical testing instruments and electronic health record systems. The Defense Health Agency, which provides healthcare services to active-duty military personnel, retirees, and their families, utilizes such diagnostic capabilities across military medical treatment facilities. Abbott Rapid Diagnostics Informatics has maintained a robust portfolio of federal contracts with the Veterans Health Administration, Indian Health Service, and Defense Health Agency, demonstrating sustained demand for its remote automated laboratory system software, device connectivity middleware, and implementation support services that are essential to modern clinical workflows in government healthcare settings.
Generated 11/6/25, 11:29 AM